What are the most common bacterial strains that cause urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Bacterial Strains Causing Urinary Tract Infections

Escherichia coli (E. coli) is the predominant bacterial strain causing urinary tract infections, accounting for approximately 80-90% of uncomplicated UTIs, with other common pathogens including Klebsiella pneumoniae, Proteus mirabilis, Enterococcus species, and Staphylococcus saprophyticus. 1, 2

Primary Causative Organisms

Uncomplicated UTIs

  • E. coli: 80-90% of cases 1, 2
  • Staphylococcus saprophyticus: Second most common in uncomplicated UTIs, particularly in young sexually active women 3, 2
  • Klebsiella pneumoniae: Increasingly common pathogen 4, 2
  • Proteus mirabilis: More common in males and patients with stones 2
  • Enterococcus species: Particularly E. faecalis 3

Complicated UTIs

The microbiology is more diverse in complicated UTIs (those with structural abnormalities, indwelling catheters, or immunocompromised hosts):

  • E. coli: Still common but represents a lower percentage (60%) 1
  • Enterococcus faecalis: More prevalent in complicated UTIs 3
  • Pseudomonas aeruginosa: Particularly in catheterized patients 3
  • Klebsiella species: More common in diabetic patients 4
  • Enterobacter species: Increasingly seen in healthcare settings 5
  • Citrobacter species: Particularly in patients with structural abnormalities 6

Pathogen Distribution by Patient Population

Pediatric Patients

In infants and young children, E. coli remains the leading cause of UTIs:

  • E. coli is the leading cause of bacteremia (60%), urinary tract infection (87.4%), and bacterial meningitis (43.7%) in infants 1

Adult Women

  • Premenopausal women: E. coli strains with fewer virulence factors than those causing symptomatic infection 1
  • Postmenopausal women: Similar organisms but higher prevalence (up to 20% in women over 80) 1

Adult Men

  • UTIs in men are considered complicated due to anatomical differences 7
  • Common pathogens include E. coli, coagulase-negative staphylococci, and Enterococcus species 1
  • Prostate infections often involve E. coli or Proteus mirabilis 6

Elderly and Institutionalized Patients

  • 25-50% of elderly women and 15-40% of elderly men in long-term care facilities have bacteriuria 1
  • More diverse pathogens including more resistant strains of Enterobacteriaceae 1

Catheterized Patients

  • Nearly 100% develop bacteriuria with long-term catheterization 1
  • Often polymicrobial infections with Pseudomonas, Proteus, Providencia, Morganella and Enterococcus species 1, 6

Changing Patterns in Antimicrobial Susceptibility

  • E. coli resistance to fluoroquinolones has increased significantly, from virtually none in 1999 to approximately 8% by 2001 in uncomplicated UTIs 3
  • Increasing resistance to first-line antibiotics has been observed globally 4
  • Pseudomonas aeruginosa isolates show approximately 40% resistance to fluoroquinolones 3

Clinical Implications

  • Understanding the likely pathogens based on patient characteristics helps guide empiric therapy
  • For uncomplicated UTIs in women, coverage for E. coli remains the priority
  • For complicated UTIs, broader coverage may be needed to address the more diverse microbiology
  • Local antibiogram data should guide empiric therapy choices due to regional variations in resistance patterns

Common Pitfalls in UTI Management

  • Assuming all UTIs have the same microbiology regardless of patient factors
  • Failing to consider local resistance patterns when selecting empiric therapy
  • Not obtaining urine cultures in complicated UTIs or treatment failures
  • Overlooking the possibility of polymicrobial infections in catheterized patients

The knowledge of common causative organisms helps clinicians select appropriate empiric antimicrobial therapy while awaiting culture results, improving outcomes and reducing unnecessary broad-spectrum antibiotic use.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bacterial resistance to antimicrobials in urinary isolates.

International journal of antimicrobial agents, 2004

Guideline

Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.